151 related articles for article (PubMed ID: 35118372)
21. Mannose Conjugated Starch Nanoparticles for Preferential Targeting of Liver Cancer.
Jain AK; Sahu H; Mishra K; Thareja S
Curr Drug Deliv; 2021; 18(3):369-380. PubMed ID: 32885751
[TBL] [Abstract][Full Text] [Related]
22. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
23. Hepatoprotective effect of curcumin and alpha-tocopherol against cisplatin-induced oxidative stress.
Palipoch S; Punsawad C; Koomhin P; Suwannalert P
BMC Complement Altern Med; 2014 Mar; 14():111. PubMed ID: 24674233
[TBL] [Abstract][Full Text] [Related]
24. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
25. Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
Chaubey P; Mishra B; Mudavath SL; Patel RR; Chaurasia S; Sundar S; Suvarna V; Monteiro M
Int J Biol Macromol; 2018 May; 111():109-120. PubMed ID: 29307805
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.
Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK
J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692
[TBL] [Abstract][Full Text] [Related]
27. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
[TBL] [Abstract][Full Text] [Related]
28. Validation of an innovative analytical method for simultaneous quantification of curcumin and fluconazole using high-performance liquid chromatography from nanostructured lipid carriers.
Araujo VHS; Fernandes LS; Dos Reis LR; Carvalho GC; Scarpa MV; Chorilli M
J Sep Sci; 2021 Dec; 44(23):4264-4273. PubMed ID: 34598311
[TBL] [Abstract][Full Text] [Related]
29. Enhanced intestinal absorption of curcumin in Caco-2 cell monolayer using mucoadhesive nanostructured lipid carriers.
Chanburee S; Tiyaboonchai W
J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):734-741. PubMed ID: 28323388
[TBL] [Abstract][Full Text] [Related]
30. Hormetic effects of curcumin on oxidative stress injury induced by trivalent arsenic in isolated rat hepatocytes.
Amirmostofian M; Akbari F; Hashemzaei M; Safaeinejad F; Tabrizian K; Arbab H; Rezaee R; Hemat Jouy S; Ghorani V; Shahraki J
Avicenna J Phytomed; 2023; 13(6):641-650. PubMed ID: 38106636
[TBL] [Abstract][Full Text] [Related]
31. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
[TBL] [Abstract][Full Text] [Related]
32. Galactosylated alginate-curcumin micelles for enhanced delivery of curcumin to hepatocytes.
Sarika PR; James NR; Kumar PR; Raj DK
Int J Biol Macromol; 2016 May; 86():1-9. PubMed ID: 26774374
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of Anti-Inflammatory Activity of Curcumin Using Phosphatidylserine-Containing Nanoparticles in Cultured Macrophages.
Wang J; Kang YX; Pan W; Lei W; Feng B; Wang XJ
Int J Mol Sci; 2016 Jun; 17(5):. PubMed ID: 27331813
[TBL] [Abstract][Full Text] [Related]
34. A Hydroxypropyl Methylcellulose-Based Solid Dispersion of Curcumin with Enhanced Bioavailability and its Hepatoprotective Activity.
Shin MS; Yu JS; Lee J; Ji YS; Joung HJ; Han YM; Yoo HH; Kang KS
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31311168
[TBL] [Abstract][Full Text] [Related]
35. Improvement of curcuminoid bioaccessibility from turmeric by a nanostructured lipid carrier system.
Park SJ; Garcia CV; Shin GH; Kim JT
Food Chem; 2018 Jun; 251():51-57. PubMed ID: 29426423
[TBL] [Abstract][Full Text] [Related]
36. Curcumin loaded mesoporous silica nanoparticles: assessment of bioavailability and cardioprotective effect.
Yadav YC; Pattnaik S; Swain K
Drug Dev Ind Pharm; 2019 Dec; 45(12):1889-1895. PubMed ID: 31549866
[TBL] [Abstract][Full Text] [Related]
37. Curcuma longa Linn. extract and curcumin protect CYP 2E1 enzymatic activity against mercuric chloride-induced hepatotoxicity and oxidative stress: A protective approach.
Joshi D; Mittal DK; Shukla S; Srivastav SK; Dixit VA
Exp Toxicol Pathol; 2017 Jul; 69(6):373-382. PubMed ID: 28336172
[TBL] [Abstract][Full Text] [Related]
38. In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system.
Wang MT; Jin Y; Yang YX; Zhao CY; Yang HY; Xu XF; Qin X; Wang ZD; Zhang ZR; Jian YL; Huang Y
Int J Nanomedicine; 2010 Aug; 5():487-97. PubMed ID: 20957171
[TBL] [Abstract][Full Text] [Related]
39. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
40. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
